| 12503467 |
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors |
Muzaffar Alam, Leah Cleary, Melissa Fleury, Zhonghua Pei, Richard Steel +2 more |
2025-12-23 |
|
| 12258354 |
AhR modulators |
Muzaffar Alam, Hilary Plake Beck, Michael Patrick Dillon, Marcos Gonzalez-Lopez |
2025-03-25 |
|
| 11912715 |
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections |
Rama Jain, Dennis Christofer Koester, James R. MANNING, Vanessa M. Marx, Daniel Poon +4 more |
2024-02-27 |
$41,139,000 |
| 11584755 |
Dihydrothieno[3,2-b]pyridine compounds |
Hilary Plake Beck, Leah Cleary, Michael Patrick Dillon, Marcos Gonzalez-Lopez, Luis Ruben P. Martinez |
2023-02-21 |
$14,496,000 |
| 11548867 |
Amido compounds as AhR modulators |
Muzaffar Alam, Hilary Plake Beck, Michael Patrick Dillon, Marcos Gonzalez-Lopez, Alice Rico |
2023-01-10 |
|
| 11530220 |
Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the modulation of AhR |
Hilary Plake Beck, Marcos Gonzalez-Lopez |
2022-12-20 |
$14,114,000 |
| 11453677 |
Tricyclic compounds useful to treat orthomyxovirus infections |
Rama Jain, Dennis Christofer Koester, James R. MANNING, Benjamin R. TAFT, Lifeng Wan +1 more |
2022-09-27 |
$36,805,000 |
| 11407764 |
AhR modulators |
Muzaffar Alam, Hilary Plake Beck, Michael Patrick Dillon, Marcos Gonzalez-Lopez |
2022-08-09 |
$7,710,000 |
| 11130759 |
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors |
Muzaffar Alam, Leah Cleary, Melissa Fleury, Zhonghua Pei, Richard Steel +2 more |
2021-09-28 |
|
| 11098051 |
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections |
Rama Jain, Dennis Christofer Koester, James R. MANNING, Vanessa M. Marx, Daniel Poon +4 more |
2021-08-24 |
$18,886,000 |
| 11084798 |
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors |
Muzaffar Alam, Leah Cleary, Melissa Fleury, Zhonghua Pei, Richard Steel +2 more |
2021-08-10 |
$13,165,000 |
| 11046691 |
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors |
Muzaffar Alam, Leah Cleary, Melissa Fleury, Zhonghua Pei, Richard Steel +2 more |
2021-06-29 |
$10,836,000 |
| 10858366 |
Tricyclic compounds useful to treat orthomyxovirus infections |
Rama Jain, Dennis Christofer Koester, James R. MANNING, Benjamin R. TAFT, Lifeng Wan +1 more |
2020-12-08 |
$132,345,000 |
| 10815250 |
AhR modulators |
Muzaffar Alam, Hilary Plake Beck, Michael Patrick Dillon, Marcos Gonzalez-Lopez |
2020-10-27 |
$10,455,000 |
| 10537561 |
CSF-1R inhibitors for treatment of brain tumors |
Dylan L. Daniel, Johanna Joyce |
2020-01-21 |
$12,199,000 |
| 10160764 |
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections |
Rama Jain, Dennis Christofer Koester, James R. MANNING, Vanessa M. Marx, Daniel Poon +4 more |
2018-12-25 |
|
| 10112931 |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
Thomas Raymond Caferro, Zhuoliang Chen, Young Shin Cho, Abran Q. Costales, Julian Levell +7 more |
2018-10-30 |
$10,292,000 |
| 9688672 |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
Thomas Raymond Caferro, Zhuoliang Chen, Young Shin Cho, Abran Q. Costales, Julian Levell +7 more |
2017-06-27 |
$19,167,000 |
| 9434719 |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
Thomas Raymond Caferro, Zhuoliang Chen, Young Shin Cho, Abran Q. Costales, Julian Levell +7 more |
2016-09-06 |
$37,307,000 |
| 8957068 |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
Thomas Raymond Caferro, Young Shin Cho, Abran Q. Costales, Huangshu Lei, Francois Lenoir +11 more |
2015-02-17 |
$25,648,000 |
| 8778951 |
Heteroaryl compounds and their uses |
Paul A. Barsanti, Cheng Hu, Jeff Jin, Robert Keyes, Robert Kucejko +5 more |
2014-07-15 |
$8,665,000 |
| 8710048 |
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
Marion Wiesmann, Weibo Wang, Mika Lindvall, Jiong Lan, Savithri Ramurthy +11 more |
2014-04-29 |
$9,214,000 |
| 8415381 |
Heteroaryl compounds and their uses |
Paul A. Barsanti, Cheng Hu, Jeff Jin, Robert Keyes, Robert Kucejko +5 more |
2013-04-09 |
$8,090,000 |
| 8329718 |
N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
Jennifer X. Qiao, Tammy C. Wang, Timur Gungor |
2012-12-11 |
$109,914,000 |
| 8293769 |
CSF-1R inhibitors, compositions, and methods of use |
Simon Ng, Keith B. Pfister, Martin Sendzik, Allan S. Wagman, Marion Wiesmann |
2012-10-23 |
$5,384,000 |
